Article
Medicine, General & Internal
Simran Anand, Chukwuemeka A. Umeh, Curren Giberson, Elias Wassel, Anphong Nguyen, Hayden Porter, Prithi Choday, Harpreet Kaur, Ankur Kundu, Jose Penaherrera
Summary: Pylephlebitis, also known as septic portal vein thrombosis, is an infective suppurative thrombosis of the portal vein and/or its intra-hepatic branches. It is often missed but easily treated with antibiotics. This case report discusses a case of pylephlebitis and the etiologies, diagnosis, and treatment of septic portal vein thrombosis.
CUREUS JOURNAL OF MEDICAL SCIENCE
(2021)
Article
Immunology
David Nygren, Johan Elf, Gustav Torisson, Karin Holm
Summary: Lemierre's syndrome is typically caused by Fusobacterium necrophorum, leading to septic internal jugular vein thrombophlebitis with subsequent septic embolization. Patients with jugular vein thrombosis were more severely affected but had similar prognosis; most of them recovered well without the need for anticoagulant therapy.
OPEN FORUM INFECTIOUS DISEASES
(2021)
Review
Medicine, General & Internal
Lisa Fusaro, Stefano Di Bella, Paola Martingano, Lory Saveria Croce, Mauro Giuffre
Summary: This study aims to investigate the etiology and clinical presentation of Pylephlebitis, including 220 cases. The most common symptoms were fever and abdominal pain, and the most frequent causes were diverticulitis and acute appendicitis. Treatment options include broad-spectrum antibiotics and, if necessary, anticoagulants.
Article
Medicine, General & Internal
Juliana S. Ali, Renee H. Kinden, Jason G. Emsley
Summary: Portal vein thrombosis (PVT) is a relatively rare condition caused by factors such as liver diseases, coagulopathies, infections, and malignancies. Clinical manifestations vary depending on the location and extent of the thrombus, and healthcare providers need to be vigilant and apply appropriate treatment strategies.
CUREUS JOURNAL OF MEDICAL SCIENCE
(2022)
Article
Obstetrics & Gynecology
Qin Shi, Deborah Shulamite Gandi, Yurong Hua, Yi Zhu, Jinhan Yao, Xiaoqing Yang, Yunzhao Xu, Yuquan Zhang
Summary: This case report describes a female patient diagnosed with right ovarian vein infectious thrombophlebitis after cesarean section. The case highlights the need to consider the potential relationship between abdominal incision hematoma and ovarian vein thrombophlebitis. Treatment included anti-inflammatory drugs and anticoagulant therapy.
BMC PREGNANCY AND CHILDBIRTH
(2021)
Article
Medicine, General & Internal
Alexandra Cloutet, Ramya Krishna Botta, Shreedhar R. Kulkarni, Pramod Kumar Ponna
Summary: Lemierre's syndrome is a rare disease that often occurs in young, healthy individuals, but its symptoms are not always typical. This article presents a case in which the diagnosis of Lemierre's syndrome was initially delayed due to the absence of internal jugular vein involvement, but was ultimately confirmed through blood culture identification.
CUREUS JOURNAL OF MEDICAL SCIENCE
(2022)
Article
Medicine, General & Internal
Lucian Giubelan, Livia Dragonu, Vlad Padureanu, Alexandru Neacsu, Mirela Manescu, Andreea Cristina Stoian, Florentina Dumitrescu
Summary: Lemierre's syndrome, first described in 1936 by Andre Lemierre, is a very rare but life-threatening condition characterized by oropharyngeal infection, internal jugular vein thrombophlebitis, and possible secondary septic metastasis. A rare case of this syndrome was diagnosed in September 2019 at our Infectious Diseases Department.
MEDICINA-LITHUANIA
(2021)
Article
Obstetrics & Gynecology
H. M. G. Wiegers, E. N. Hamulyak, S. E. Damhuis, J. R. van Duuren, S. Darwish Murad, L. J. J. Scheres, S. J. Gordijn, J. Leentjens, J. J. Duvekot, M. N. Lauw, B. A. Hutten, S. Middeldorp, W. Ganzevoort
Summary: Women previously diagnosed with Budd-Chiari syndrome and/or portal vein thrombosis, with or without concomitant portal hypertension, can achieve relatively good pregnancy outcomes, with a high rate of term live births and lower risk of maternal and neonatal complications. Therefore, these conditions should not be considered as absolute contraindications for pregnancy, and individualized counseling and multidisciplinary pregnancy surveillance are essential.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
(2022)
Article
Hematology
Marijke Allain Wouterlood, Isabelle Malhame, Kateri Levesque, Natalie Dayan, Michele Mahone, Anne-Marie Cote, Annabelle Cumyn, Mandy Malick, Nadine Sauve
Summary: Pelvic vein thrombosis (PVT) in pregnancy is a rare complication that is often diagnosed in the early postpartum period, presenting with symptoms such as abdominal pain and fever. Risk factors include surgery and peripartum infections. Treatment includes antibiotics and anticoagulation, but there is a high risk of PE and IVC clot extension, leading to prolonged hospitalization.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
(2021)
Article
Radiology, Nuclear Medicine & Medical Imaging
Bo Wei, Zhiyin Huang, Hao Wu, Yang Tai, Huan Tong, Qian Li, Zhidong Wang, Rui Yang, Chengwei Tang
Summary: This study compared the clinical outcomes of TIPS creation and PVS in patients with noncirrhotic CTPV. The results showed that PVS had lower stent occlusion rate, lower risk of variceal rebleeding, and fewer adverse events compared to TIPS, indicating that PVS may be a preferable alternative for the treatment of noncirrhotic CTPV.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
(2023)
Article
Medicine, General & Internal
Maxime Taquet, Masud Husain, John R. Geddes, Sierra Luciano, Paul J. Harrison
Summary: This study found that the incidence of cerebral venous thrombosis and portal vein thrombosis after a COVID-19 diagnosis was significantly higher than in cohorts of individuals who received mRNA vaccines or had influenza.
Article
Medicine, General & Internal
Hanxiao You, Jiuliang Zhao, Can Huang, Xinping Tian, Mengtao Li, Xiaofeng Zeng
Summary: Portal vein thrombosis (PVT) is a rare and severe clinical phenotype of antiphospholipid syndrome (APS) with a poor prognosis. Anticoagulation therapy can increase the re-canalization rate of the thrombus and improve the prognosis. For patients with APS, double aPL positivity, thrombocytopenia, and inflammation may be associated factors of PVT.
FRONTIERS IN MEDICINE
(2021)
Article
Medicine, General & Internal
Hiu L. A. Yuen, Wendy Fang, Huyen Tran, Sanjeev D. Chunilal
Summary: This study found that anticoagulation is unnecessary for most UESVT patients, especially those without cancer.
INTERNAL MEDICINE JOURNAL
(2022)
Article
Cardiac & Cardiovascular Systems
Wenzhu Li, Chase W. Kessinger, Makoto Orii, Hang Lee, Lang Wang, Ido Weinberg, Michael R. Jaff, Guy L. Reed, Peter Libby, Ahmed Tawakol, Peter K. Henke, Farouc A. Jaffer
Summary: The study found that RBF can reduce thrombus burden parameters and vein wall fibrosis and inflammation in mice on day 4 but not later. In the clinical study, PCDT demonstrated maximal benefits in improving quality of life and symptom scores for patients with symptom-onset-to-randomization timeframes of 4 to 8 days.
Article
Surgery
Zhou Zheng, Qingsheng Yu, Hui Peng, Wanzong Zhang, Yi Shen, Hui Feng, Long Huang, Fuhai Zhou, Qi Zhang, Qin Wang
Summary: This study analyzed the changes in portal vein hemodynamics and risk factors for portal vein system thrombosis (PVST) after splenectomy in Wilson's disease patients with portal hypertension. The results showed that splenectomy can relieve portal hypertension by reducing hemodynamic indices, but it is associated with a high incidence of PVST. Platelet levels on the 7th day and D-dimer levels on the 14th day after surgery were found to be significant factors for PVST. The predictive model developed in this study can accurately predict PVST.
FRONTIERS IN SURGERY
(2022)
Article
Emergency Medicine
Satoshi Yoshikawa, Takeshi Ueda, Emi Yamashita
JOURNAL OF EMERGENCY MEDICINE
(2020)
Article
Multidisciplinary Sciences
Mihiro Kaga, Takeshi Ueda, Satoshi Yoshikawa
Summary: Glial fibrillary acidic protein astrocytopathy is an autoimmune meningoencephalomyelitis characterized by fever, headache, movement disorders, and autonomic symptoms. Diagnosis is based on the presence of antibodies against glial fibrillary acidic protein in spinal fluid. There is no standard treatment for this disease.
